[Summary] Continuously creating value for the cause of human health
Wuhan Hualianke Biotechnology Co., Ltd. is a high-tech enterprise with the research and development of human disease animal models as its core business, and is the only "Hubei Provincial Specialized Company for Laboratory Animal Model Research" approved by the Hubei Science and Technology Department. The company has built over 500 square meters of laboratory animal barrier environment facilities and conventional environment facilities, as well as over 1,700 square meters of laboratory animal R&D platforms and scientific testing platforms, equipped with over 10 million yuan worth of instruments and equipment. It is planning the construction of Phase II, including over 4,000 square meters of laboratory animal scientific research service center and over 2,000 square meters of product R&D and production center. The company mainly provides conventional animal strains and their model supply and technical services, animal experiment technical services, drug screening and evaluation technical services, experimental antibodies and detection kits and other experimental materials and consumables, and customized project services. The company currently has over 150 employees and has successfully obtained 47 invention patents and utility model patents. The company has established industry-university-research cooperation with several well-known universities in Wuhan; it has passed ISO9001 quality management system certification and is a leading enterprise in laboratory animal R&D in Hubei Province, having received honors such as above-scale service enterprise, Optics Valley Gazelle Enterprise, Science and Technology Little Giant Enterprise, and co-construction council member unit of the National-Local Joint Engineering Laboratory for New Contraceptive Technologies of Huazhong University of Science and Technology. The company will focus on building the germ-free humanized product plan, disease germ-free mouse strain plan, and germ-free animal phenome plan, providing research subjects and platforms for preclinical CRO.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows